首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1948371

2026年全球腫瘤消融設備市場報告

Tumor Ablation Therapy Devices Global Market Report 2026

出版日期: 2026年02月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，腫瘤消融治療設備的市場規模迅速擴張，預計將從2025年的8.2億美元成長到2026年的9.5億美元，複合年成長率達15.0%。過去幾年的成長可歸因於多種因素，例如癌症發病率上升、腫瘤治療中心擴張、微創療法的普及、先進影像技術的廣泛應用以及人們對器官保留療法的日益青睞。

預計未來幾年腫瘤消融設備市場將快速成長，到2030年市場規模將達到16.1億美元，複合年成長率（CAGR）為14.2%。預測期內的成長將主要受以下因素驅動：精準腫瘤學投資的增加、門診癌症治療需求的成長、先進消融技術的推廣應用、影像和治療系統整合程度的提高，以及對個人化癌症治療的日益重視。預測期內的關鍵趨勢包括：微創腫瘤消融技術的日益普及、影像引導消融系統的廣泛應用、對器官特異性消融技術的需求不斷成長、經皮治療方法的拓展，以及對精準腫瘤學的日益重視。

受癌症發生率不斷上升的推動，腫瘤消融設備市場正在成長。癌症是主要死因之一，約佔全球死亡人數的六分之一。腫瘤消融術是一種微創手術，廣泛用於治療包括肺、肝、腎和骨骼在內的各種部位的腫瘤。例如，根據美國癌症協會（一家總部位於美國的非營利健康組織）估計，2023年美國預計將新增約1,958,310例癌症病例，高於2022年報告的1,918,030例。這種治療方法為癌症患者提供了一種有效的治療選擇，尤其適用於對化療或放射線治療無反應的患者，從而推動了腫瘤消融設備市場的成長。

為了獲得競爭優勢，腫瘤消融設備市場的主要企業正致力於開發微創療法。微創療法因其能夠在最大限度減少對周圍健康組織損傷的同時，實現精準有效的治療，而被廣泛應用於腫瘤消融領域。例如，2023年8月，美國公司Francis Medical憑藉其微創水蒸氣消融療法乳酪餡餅，獲得了美國食品藥物管理局（FDA）的突破性醫療器材認定。 Francis Medical是一家為攝護腺癌、腎臟癌和膀胱癌提供微創治療方案的公司。該認定旨在加速此類醫療設備醫療設備的研發和法規核准，並使患者能夠更早獲得治療。 Vanquish利用少量無菌水蒸氣中所含的熱能，透過簡單的經尿道手術將標靶治療輸送到癌組織。該治療方法旨在有效破壞癌細胞，同時保護周圍組織，從而降低傳統前列腺癌治療中常見的嚴重副作用風險。

關鍵技術和未來趨勢
- 生物技術、基因組學和精準醫學
- 人工智慧與自主智慧
- 工業4.0和智慧製造
- 數位化、雲端運算、巨量資料、網路安全
- 永續性、氣候技術和循環經濟
主要趨勢
- 微創腫瘤消融手術的應用日益增多
- 影像導引消融系統的應用日益廣泛
- 對器官特異性消融技術的需求日益成長
- 拓展經皮治療方法
- 日益關注精準腫瘤學

第5章終端用戶產業市場分析

醫院
腫瘤診所
專科癌症中心
介入放射中心
學術醫療機構

第6章市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章全球策略分析架構、目前市場規模、市場對比及成長率分析

全球腫瘤消融設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
全球腫瘤消融設備市場規模、對比及成長率分析
全球腫瘤消融設備市場表現：規模與成長，2020-2025年
全球腫瘤消融設備市場預測：規模與成長，2025-2030年，2035年預測

第8章全球潛在市場總量（TAM）

第9章市場細分

透過技術
射頻消融、微波消融、冷凍消融、不可逆電穿孔消融及其他技術
透過治療
外科手術、腹腔鏡手術、經皮
透過使用
腎癌、肝癌、乳癌、肺癌、攝護腺癌及其他適應症
最終用戶
醫院、腫瘤診所和其他最終用戶
按類型細分：射頻消融術（RFA）
單極射頻消融裝置，雙極射頻消融裝置
按類型細分：微波消融
高頻微波設備、低頻微波設備
按類型細分：冷凍消融
液態氮氮基設備，氬氣基設備
按類型細分：不可逆電穿孔消融術（IRE）
NanoKnife消融系統，高壓脈衝產生器
按類型細分：其他技術
雷射消熔設備、超音波導引高強度聚焦超音波（HIFU）和化學消融技術

第10章區域與國家分析

全球腫瘤消融設備市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
全球腫瘤消融設備市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章亞太市場

第12章：中國市場

第13章印度市場

第14章日本市場

第15章：澳洲市場

第16章印尼市場

第17章韓國市場

第18章台灣市場

第19章東南亞市場

第20章：西歐市場

第21章英國市場

第22章德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章東歐市場

第27章：俄羅斯市場

第28章北美市場

第29章：美國市場

第30章：加拿大市場

第31章南美洲市場

第32章：巴西市場

第33章中東市場

第34章：非洲市場

第35章市場監理與投資環境

第36章：競爭格局與公司概況

腫瘤消融設備市場：競爭格局及市場佔有率（2024年）
腫瘤消融設備市場：公司估值矩陣
腫瘤消融設備市場：公司概況
- Galil Medical Inc.
- Misonix Inc.
- HealthTronics Inc.
- AngioDynamics Inc.
- Boston Scientific Corporation

第37章：其他領先和創新企業

Medtronic plc, EDAP TMS SA, NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc.

第38章全球市場競爭基準分析與儀錶板

第39章重大併購

第40章：高潛力市場國家、細分市場與策略

2030年腫瘤消融設備市場：提供新機會的國家
2030年腫瘤消融設備市場：充滿新機會的細分市場
2030年腫瘤消融設備市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第41章附錄

簡介目錄

Product Code: ME4MTATD01_G26Q1

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

Tariffs are influencing the tumor ablation therapy devices market by increasing costs of imported generators, probes, imaging components, cryogenic systems, and electronic controls. Hospitals and oncology centers in North America and Europe are most affected due to reliance on imported high-value medical equipment, while Asia-Pacific faces higher production and export costs. These tariffs are increasing treatment system prices and extending procurement timelines. However, they are also driving localized device manufacturing, regional assembly operations, and innovation in cost-efficient ablation technologies.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.82 billion in 2025 to $0.95 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of oncology treatment centers, rising adoption of minimally invasive therapies, availability of advanced imaging technologies, growing preference for organ-preserving treatments.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing investments in precision oncology, rising demand for outpatient cancer treatments, expansion of advanced ablation technologies, growing integration of imaging and therapy systems, increasing focus on personalized cancer care. Major trends in the forecast period include increasing adoption of minimally invasive tumor ablation procedures, rising use of image-guided ablation systems, growing demand for organ-specific ablation technologies, expansion of percutaneous treatment approaches, enhanced focus on precision oncology.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

Major companies operating in the tumor ablation therapy devices market are focusing on developing minimally invasive therapies to gain a competitive edge. Minimally invasive therapy is widely used in tumor ablation as it enables precise and effective treatment while minimizing damage to surrounding healthy tissues. For instance, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation is intended to accelerate the device's development and regulatory review, potentially enabling faster patient access. Vanquish uses the thermal energy contained in a small amount of sterile water vapor to deliver targeted treatment to cancerous tissue through a simple transurethral procedure. The therapy is designed to effectively destroy cancer cells while preserving nearby structures, thereby reducing the risk of severe side effects commonly associated with conventional prostate cancer treatments.

In October 2024, ExcelFin Acquisition Corp, a US-based publicly traded special purpose acquisition company, merged with Betters Medical Investment Holdings Limited (Baird Medical) for an undisclosed amount. Through this merger, ExcelFin plans to take Baird Medical public and support its growth strategy, allowing the company to expand its microwave ablation (MWA) technology portfolio and accelerate its penetration into the U.S. and global markets. Betters Medical Investment Holdings Limited is a China-based medical device company that develops microwave ablation systems for minimally invasive tumor treatment.

Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,

North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
2) By Treatment: Surgical; Laparoscopic; Percutaneous
3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
4) By End User: Hospitals; Oncology Clinics; Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation; Medtronic plc; EDAP TMS S.A.; NeuWave Medical Inc.; BVM Medical Limited; Erbe Elektromedizin GmbH; Theraclion; INTIO Inc.; Olympus Corporation; Stryker Corporation; Merit Medical Systems Inc.; Insightec Ltd.; Terumo Corporation; Monteris Medical Corporation; IceCure Medical Ltd.; Profound Medical Inc.; Alpinion Medical Systems Co. Ltd.; Sonacare Medical; Hologic Inc.; Endocare Inc.; Bovie Medical Corporation;
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Tumor Ablation Therapy Devices Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Tumor Ablation Therapy Devices Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Tumor Ablation Therapy Devices Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Tumor Ablation Therapy Devices Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics And Precision Medicine
- 4.1.2 Artificial Intelligence And Autonomous Intelligence
- 4.1.3 Industry 4.0 And Intelligent Manufacturing
- 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
- 4.1.5 Sustainability, Climate Tech And Circular Economy
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Minimally Invasive Tumor Ablation Procedures
- 4.2.2 Rising Use Of Image-Guided Ablation Systems
- 4.2.3 Growing Demand For Organ-Specific Ablation Technologies
- 4.2.4 Expansion Of Percutaneous Treatment Approaches
- 4.2.5 Enhanced Focus On Precision Oncology

5. Tumor Ablation Therapy Devices Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Oncology Clinics
5.3 Specialty Cancer Centers
5.4 Interventional Radiology Centers
5.5 Academic Medical Institutions

6. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tumor Ablation Therapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Tumor Ablation Therapy Devices Market Size, Comparisons And Growth Rate Analysis
7.3. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tumor Ablation Therapy Devices Market Segmentation

9.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
9.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Surgical, Laparoscopic, Percutaneous
9.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
9.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Oncology Clinics, Other End Users
9.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Monopolar RFA Devices, Bipolar RFA Devices
9.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
High-frequency Microwave Devices, Low-frequency Microwave Devices
9.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Liquid Nitrogen-based Devices, Argon Gas-based Devices
9.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
NanoKnife Ablation Systems, High-voltage Pulse Generators
9.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques

10. Tumor Ablation Therapy Devices Market Regional And Country Analysis

10.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tumor Ablation Therapy Devices Market

11.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tumor Ablation Therapy Devices Market

12.1. China Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tumor Ablation Therapy Devices Market

13.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tumor Ablation Therapy Devices Market

14.1. Japan Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tumor Ablation Therapy Devices Market

15.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tumor Ablation Therapy Devices Market

16.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tumor Ablation Therapy Devices Market

17.1. South Korea Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tumor Ablation Therapy Devices Market

18.1. Taiwan Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tumor Ablation Therapy Devices Market

19.1. South East Asia Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tumor Ablation Therapy Devices Market

20.1. Western Europe Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tumor Ablation Therapy Devices Market

21.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tumor Ablation Therapy Devices Market

22.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tumor Ablation Therapy Devices Market

23.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tumor Ablation Therapy Devices Market

24.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tumor Ablation Therapy Devices Market

25.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tumor Ablation Therapy Devices Market

26.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tumor Ablation Therapy Devices Market

27.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tumor Ablation Therapy Devices Market

28.1. North America Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tumor Ablation Therapy Devices Market

29.1. USA Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tumor Ablation Therapy Devices Market

30.1. Canada Tumor Ablation Therapy Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tumor Ablation Therapy Devices Market

31.1. South America Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tumor Ablation Therapy Devices Market

32.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tumor Ablation Therapy Devices Market

33.1. Middle East Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tumor Ablation Therapy Devices Market

34.1. Africa Tumor Ablation Therapy Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tumor Ablation Therapy Devices Market Regulatory and Investment Landscape

36. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

36.1. Tumor Ablation Therapy Devices Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Tumor Ablation Therapy Devices Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Tumor Ablation Therapy Devices Market Company Profiles
- 36.3.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc.

38. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

40. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

40.1 Tumor Ablation Therapy Devices Market In 2030 - Countries Offering Most New Opportunities
40.2 Tumor Ablation Therapy Devices Market In 2030 - Segments Offering Most New Opportunities
40.3 Tumor Ablation Therapy Devices Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies